This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2019 Nov;14(21):2777-2782.

doi: 10.2217/nnm-2019-0321. Epub 2019 Nov 22.

Perspectives, issues and solutions in RNAi therapy: the expected and the less expected

Affiliations

PMID: 31752594
DOI: 10.2217/nnm-2019-0321

Review

Perspectives, issues and solutions in RNAi therapy: the expected and the less expected

Achim Aigner. Nanomedicine (Lond). 2019 Nov.

. 2019 Nov;14(21):2777-2782.

doi: 10.2217/nnm-2019-0321. Epub 2019 Nov 22.

Author

Affiliation

¹ Rudolf-Boehm-Institute for Pharmacology & Toxicology, Clinical Pharmacology, University of Leipzig, Faculty of Medicine, Leipzig, Germany.

PMID: 31752594
DOI: 10.2217/nnm-2019-0321

No abstract available

Keywords: RNAi; clinical translation; delivery; nanocarrier; siRNA; siRNA target identification.

PubMed Disclaimer

Similar articles

Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
Maheshwari R, Tekade M, Gondaliya P, Kalia K, D'Emanuele A, Tekade RK. Maheshwari R, et al. Nanomedicine (Lond). 2017 Nov;12(21):2653-2675. doi: 10.2217/nnm-2017-0210. Epub 2017 Sep 29. Nanomedicine (Lond). 2017. PMID: 28960165 Review.
Overcoming cellular barriers for RNA therapeutics.
Dowdy SF. Dowdy SF. Nat Biotechnol. 2017 Mar;35(3):222-229. doi: 10.1038/nbt.3802. Epub 2017 Feb 27. Nat Biotechnol. 2017. PMID: 28244992 Review.
Development of siRNA Therapeutics for the Treatment of Liver Diseases.
Holm A, Løvendorf MB, Kauppinen S. Holm A, et al. Methods Mol Biol. 2021;2282:57-75. doi: 10.1007/978-1-0716-1298-9_5. Methods Mol Biol. 2021. PMID: 33928570 Review.
siRNA therapeutics: a clinical reality.
Saw PE, Song EW. Saw PE, et al. Sci China Life Sci. 2020 Apr;63(4):485-500. doi: 10.1007/s11427-018-9438-y. Epub 2019 Apr 30. Sci China Life Sci. 2020. PMID: 31054052 Review.
Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J, Farzan M. Varshosaz J, et al. World J Gastroenterol. 2015 Nov 14;21(42):12022-41. doi: 10.3748/wjg.v21.i42.12022. World J Gastroenterol. 2015. PMID: 26576089 Free PMC article. Review.

See all similar articles

Cited by

An optimized live bacterial delivery vehicle safely and efficaciously delivers bacterially transcribed therapeutic nucleic acids.
Mora DSO, Cox M, Magunda F, Williams AB, Linke L. Mora DSO, et al. Eng Life Sci. 2023 Feb 5;23(3):e2200037. doi: 10.1002/elsc.202200037. eCollection 2023 Mar. Eng Life Sci. 2023. PMID: 36874611 Free PMC article.
Effect of Allele-Specific Clcn7^G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background.
Saffie-Siebert S, Alam I, Sutera FM, Dehsorkhi A, Torabi-Pour N, Baran-Rachwalska P, Iamartino L, Teti A, Maurizi A, Gerard-O'Riley RL, Acton D, Econs MJ. Saffie-Siebert S, et al. Calcif Tissue Int. 2024 Jul;115(1):85-96. doi: 10.1007/s00223-024-01222-3. Epub 2024 May 11. Calcif Tissue Int. 2024. PMID: 38733412
Combinational treatments of RNA interference and extracellular vesicles in the spinocerebellar ataxia.
Ding Y, Zhang Y, Liu X. Ding Y, et al. Front Mol Neurosci. 2022 Oct 13;15:1043947. doi: 10.3389/fnmol.2022.1043947. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36311034 Free PMC article. Review.
Lipid nanoparticle encapsulated large peritoneal macrophages migrate to the lungs via the systemic circulation in a model of clodronate-mediated lung-resident macrophage depletion.
Oza D, Ivich F, Pace J, Yu M, Niedre M, Amiji M. Oza D, et al. Theranostics. 2024 Apr 8;14(6):2526-2543. doi: 10.7150/thno.91062. eCollection 2024. Theranostics. 2024. PMID: 38646640 Free PMC article.
Targeted Delivery of Gene Silencing in Fungi Using Genetically Engineered Bacteria.
Niño-Sánchez J, Chen LH, De Souza JT, Mosquera S, Stergiopoulos I. Niño-Sánchez J, et al. J Fungi (Basel). 2021 Feb 9;7(2):125. doi: 10.3390/jof7020125. J Fungi (Basel). 2021. PMID: 33572197 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Atypon